The Scripps Research Institute Offers Promising Rheumatoid Arthritis Treatment

For the over two million people in the U.S. that suffer from rheumatoid arthritis, there is good news out of The Scripps Research Institute (TSRI) in Florida. A new synthesized compound, SR2211, has been shown to dramatically reduce joint inflammation in mice after the first eight to ten days of